Immunonanoshells for targeted photothermal ablation of tumor cells

International Journal of Nanomedicine

Volumn 1, Issue 2, 2006, Pages 149-154

  Lowery, Amanda R ^a   Gobin, André M ^a   Day, Emily S ^a   Halas, Naomi J ^a   West, Jennifer L ^a  

^a Rice University   (United States)

Author keywords

Antibody; Cancer; Immunonanoshells; Nanoshells; Photothermal; Targeting

Indexed keywords

ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; NANOPARTICLE;

ARTICLE; BREAST TUMOR; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC THERAPY; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; PATHOLOGY; PHOTOTHERAPY; TUMOR CELL LINE;

ANTIBODIES; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; HYPERTHERMIA, INDUCED; IMMUNOTHERAPY; NANOPARTICLES; PHOTOTHERAPY; RECEPTOR, ERBB-2;

EID: 34548620551     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/nano.2006.1.2.149     Document Type: Article

References (27)

1. Anderson SA, Rader RK, Westlin WF, et al. 2000. Magnetic resonance contrast enhancement of neovasculature with αvα3-targeted nanoparticles. Magn Reson Med, 44:433-9.
2. Arap W, Pasqualini R, Ruoslahti E. 1998. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science Magazine, 16:377-80.
3. Averitt RD, Westcott SL, Halas NJ. 1999. Linear optical properties of gold nanoshells. J Opt Soc Am B, 16:1824-32.
4. Backer MV, Backer JM. 2001. Targeting endothelial cells overexpressing VEGFR-2: Selective toxicity of shiga-like toxin-VEGF fusion proteins. Bioconjug Chem, 12:1066-73.
5. Carlsson J, Nordgren H, Sjostrom J, et al. 2004. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. Br J Cancer, 90:2344-8.
6. Cerletti A, Drewe J, Fricker G, et al. 2000. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J Drug Target, 8:435-46.
7. Cortez-Retamozo V, Lauwereys M, Hassanzadeh G, et al. 2002. Efficient tumor targeting by single-domain antibody fragments of camels. Int J Cancer, 98:456-62.
8. Duff DG, Baiker A, Edwards P. 1993. A new hydrosol of gold clusters. 1. Formation and particle size variation. Langmuir, 9:2301-9.
9. Hashizume H, Baluk P, Morikawa S, et al. 2000. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol, 156:1363-80.
10. Hirsch LR, Stafford RJ, Bankson JA, et al. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A, 100:13549-54.
11. Kämmerer U, Thanner F, Kapp M, et al. 2003. Expression of tumor markers on breast and ovarian cancer cell lines. Anticancer Res, 23:1051-6.
12. Loo C, Lin A, Hirsch L, et al. 2004. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat, 3:33-40.
13. Loo C, Lowery A, Halas N, et al. 2005. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett, 5:709-11.
14. McDermont RS, Beuvon F, Pauly M, et al. 2002-03. Tumor antigens and antigen-presenting capacity in breast cancer. Pathobiology, 70:324-32.
15. Noble CO, Kirpotin DB, Hayes ME, et al. 2004. Development of ligand-targeted liposomes for cancer therapy. Expert Opin Ther Targets, 8:335-53.
16. Oldenburg SJ, Averitt RD, Westcott SL, et al. 1998. Nanoengineering of optical resonances. Chem Phys Lett, 288:243-7.
17. O'Neal DP, Hirsch LR, Halas NJ, et al. 2004. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett, 209:171-6.
18. Park JW, Hong K, Kirpotin DB, et al. 2002. Anti-HER2 immunoliposomes:enhanced efficacy attributable to targeted delivery. Clin Cancer Res, 8:1172-81.
19. Park JW, Kirpotin DB, Hong K, et al. 2001. Tumor targeting using anti-her2 immunoliposomes. J Control Release, 74:95-113.
20. Reynolds AR, Moghimi SM, Hodivala-Dilke K. 2003. Nanoparticle-mediated gene delivery to tumor neovasculature. Trend Mol Med, 9:2-4.
21. Slamon DJ, Godolphin W, Jones LA, et al. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244:707-12.
22. Stöber W, Fink A, Bohn E. 1968. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci, 26:62-9.
23. Tarli L, Balza E, Viti F, et al. 1999. A high affinity human antibody that targets tumoral blood vessels. Blood, 94:192-8.
24. Verel I, Heider K-H, Siegmund M, et al. 2002. Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts. Int J Cancer, 99:396-402.
25. Weissleder HB. 2001. A clearer vision for in vivo imaging. Nat Biotechnol, 19:316-7.
26. Welch A, van Gemert M (eds). 1995. Optical-thermal response of laser-irradiated tissues. New York: Plenum Press.
27. Wu X, Liu H, Liu J, et al. 2003. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol, 21:41-6.